TP53 and cancer: We provided further evidence regarding that when combined with p53 activator NSC59984, the cytotoxicity of C2-ceramide in MCF-7 cells was significantly enhanced, indicating that the activation of p53 and its downstream signaling and the anti-cancer effect induced by C2-ceramide were two individual actions, and so the effect of combined treatment was evident (Figure 5B).